Ads

You May Also Like

ThromboGenics Business Update – H1 2017

Press release                                                          7 September, 2017Regulated Information Good Progress in Advancing Diabetic Eye Disease Portfolio ...

Tyme Provides Clinical and Corporate Update for Fiscal Third Quarter 2017

NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage ...